Inhibition of nitric oxide is a good therapeutic target for bladder tumors that express iNOS

Nitric Oxide - Biology and Chemistry

Volumn 36, Issue , 2014, Pages 11-18

  Belgorosky, Denise ^a   Langle, Yanina ^a   Cormick, Bárbara Prack Mc ^a   Colombo, Lucas ^a   Sandes, Eduardo ^a   Eiján, Ana María ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Bladder cancer; iNOS; Nitric oxide; Orthotopic murine model

Indexed keywords

GELATINASE A; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; N(G) NITROARGININE METHYL ESTER; PROTEIN KINASE B; PROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CANCER SIZE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR INVASION; URINE;

MURINAE;

4′,6-DIAMINO-2-PHENYLINDOLE; BC; BLADDER CANCER; CM; CONDITIONED MEDIUM; DAPI; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENOS; INDUCIBLE NITRIC OXIDE SYNTHASE; INOS; L-NAME; MATRIX METALLOPROTEINASE; MMP; N-NITRO-L-ARGININE-METHYL-ESTERHCL; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NMI; NNOS; NO; NONMUSCLE INVASIVE; ORTHOTOPIC MURINE MODEL; UPA; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; URINARY BLADDER NEOPLASMS;

EID: 84887765144     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2013.10.010     Document Type: Article

References (43)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics CA Cancer J. Clin. 60 2010 277 300
2. A.B. Alexandroff, A.M. Jackson, M.A. O'Donnell, and K. James BCG immunotherapy of bladder cancer: 20 years on Lancet 353 1999 1689 1694 (Pubitemid 29224536)
3. R.G. Knowles, and S. Moncada Nitric oxide synthases in mammals Biochem. J. 298 Pt 2 1994 249 258 (Pubitemid 24072462)
4. X.R. Wu Urothelial tumorigenesis: a tale of divergent pathways Nat. Rev. Cancer 5 2005 713 725
5. M. Bjorklund, and E. Koivunen Gelatinase-mediated migration and invasion of cancer cells Biochim. Biophys. Acta 1755 2005 37 69 (Pubitemid 40720240)
6. Y.X. Liu, K. Liu, Q. Feng, Z.Y. Hu, H.Z. Liu, and G.Q. Fu Tissue-type plasminogen activator and its inhibitor plasminogen activator inhibitor type 1 are coordinately expressed during ovulation in the rhesus monkey Endocrinology 145 2004 1767 1775 (Pubitemid 38402385)
7. C. Lodillinsky, V. Rodriguez, L. Vauthay, E. Sandes, A. Casabe, and A.M. Eijan Novel invasive orthotopic bladder cancer model with high cathepsin B activity resembling human bladder cancer J. Urol. 182 2009 749 755
8. E.O. Sandes, C. Lodillinsky, Y. Langle, D. Belgorosky, L. Marino, and L. Gimenez Inducible nitric oxide synthase and PPARgamma are involved in bladder cancer progression J. Urol. 188 2012 967 973
9. L.A. Ridnour, D.D. Thomas, C. Switzer, W. Flores-Santana, J.S. Isenberg, and S. Ambs Molecular mechanisms for discrete nitric oxide levels in cancer Nitric Oxide 19 2008 73 76
10. M. Ziche, L. Morbidelli, E. Masini, S. Amerini, H.J. Granger, and C.A. Maggi Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P J. Clin. Invest. 94 1994 2036 2044 (Pubitemid 24348244)
11. C.J. van der Woude, J.H. Kleibeuker, P.L. Jansen, and H. Moshage Chronic inflammation, apoptosis and (pre-)malignant lesions in the gastro-intestinal tract Apoptosis 9 2004 123 130 (Pubitemid 38987589)
12. E.O. Sandes, A.G. Faletti, M.D. Riveros, C. Vidal Mdel, L. Gimenez, and A.R. Casabe Expression of inducible nitric oxide synthase in tumoral and non-tumoral epithelia from bladder cancer patients Nitric Oxide 12 2005 39 45 (Pubitemid 41071408)
13. X.G. Guo, J.Z. Chen, J.H. Zhu, F.R. Zhang, Y.G. Qiu, and L.L. Zhao Interleukin-1beta upregulates matrix metalloproteinase-2 expression and activity in cardiac fibroblasts via nitric oxide synthase pathway Zhonghua Xin Xue Guan Bing Za Zhi 37 2009 63 68
14. T. Hamada, S. Duarte, S. Tsuchihashi, R.W. Busuttil, and A.J. Coito Inducible nitric oxide synthase deficiency impairs matrix metalloproteinase-9 activity and disrupts leukocyte migration in hepatic ischemia/reperfusion injury Am. J. Pathol. 174 2009 2265 2277
15. Y. Langle, C. Lodillinsky, D. Belgorosky, E.O. Sandes, and A.M. Eijan Role of peroxisome proliferator activated receptor-gamma in bacillus Calmette-guerin bladder cancer therapy J. Urol. 188 2012 2384 2390
16. C. Lodillinsky, Y. Langle, A. Guionet, A. Gongora, A. Baldi, and E.O. Sandes Bacillus calmette guerin induces fibroblast activation both directly and through macrophages in a mouse bladder cancer model PLoS One 5 2010 e13571
17. A.J. Urtreger, V.C. Grossoni, K.B. Falbo, M.G. Kazanietz, and E.D. Bal de Kier Joffe Atypical protein kinase C-zeta modulates clonogenicity, motility, and secretion of proteolytic enzymes in murine mammary cells Mol. Carcinog. 42 2005 29 39 (Pubitemid 40041483)
18. V. Alvarez, C. Lodillinsky, S. Umerez, E. Sandes, and A.M. Eijan Inhibition of bacillus calmette-guerin-induced nitric oxide in bladder tumor cells may improve BCG treatment Int. J. Mol. Med. 16 2005 565 571
19. L.J. Ignarro The unique role of nitric oxide as a signaling molecule in the cardiovascular system Ital. Heart J. 1 Suppl. 3 2000 S28 9
20. M. Ziche, A. Parenti, F. Ledda, P. Dell'Era, H.J. Granger, and C.A. Maggi Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF Circ. Res. 80 1997 845 852 (Pubitemid 27230059)
21. S.P. Hussain, P. He, J. Subleski, L.J. Hofseth, G.E. Trivers, and L. Mechanic Nitric oxide is a key component in inflammation-accelerated tumorigenesis Cancer Res. 68 2008 7130 7136
22. J.R. Hickok, and D.D. Thomas Nitric oxide and cancer therapy: the emperor has NO clothes Curr. Pharm. Des. 16 2010 381 391
23. S. Ghosh, M.J. May, and E.B. Kopp NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses Annu. Rev. Immunol. 16 1998 225 260 (Pubitemid 28183365)
24. H. Kleinert, C. Euchenhofer, I. Ihrig-Biedert, and U. Forstermann Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B Mol. Pharmacol. 49 1996 15 21
25. N. Mukaida, M. Morita, Y. Ishikawa, N. Rice, S. Okamoto, and T. Kasahara Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression J. Biol. Chem. 269 1994 13289 13295
26. Y.J. Jeon, S.H. Han, Y.W. Lee, S.S. Yea, and K.H. Yang Inhibition of NF-kappa B/Rel nuclear translocation by dexamethasone: mechanism for the inhibition of iNOS gene expression Biochem. Mol. Biol. Int. 45 1998 435 441 (Pubitemid 28369825)
27. S. Pervin, R. Singh, E. Hernandez, G. Wu, and G. Chaudhuri Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway Cancer Res. 67 2007 289 299 (Pubitemid 46142787)
28. M. Sanyal, T.C. Nag, and C. Das Localization of nitric oxide synthase in human trophoblast cells: role of nitric oxide in trophoblast proliferation and differentiation Am. J. Reprod. Immunol. 43 2000 70 77 (Pubitemid 30088283)
29. M. Keith Bechtel, and B. Bonavida Inhibitory effects of 17beta-estradiol and progesterone on ovarian carcinoma cell proliferation: a potential role for inducible nitric oxide synthase Gynecol. Oncol. 82 2001 127 138 (Pubitemid 32634965)
30. C.E. Eyler, Q. Wu, K. Yan, J.M. MacSwords, D. Chandler-Militello, and K.L. Misuraca Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2 Cell 146 2011 53 66
31. S. Huguenin, J. Fleury-Feith, L. Kheuang, M.C. Jaurand, M. Bolla, and J.P. Riffaud Nitrosulindac (NCX 1102): a new nitric oxide-donating non-steroidal anti-inflammatory drug (NO-NSAID), inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines Prostate 61 2004 132 141 (Pubitemid 39244700)
32. J. Zheng, Y. Wen, J.L. Austin, and D.B. Chen Exogenous nitric oxide stimulates cell proliferation via activation of a mitogen-activated protein kinase pathway in ovine fetoplacental artery endothelial cells Biol. Reprod. 74 2006 375 382 (Pubitemid 43122289)
33. Q. Shi, Q. Xiong, B. Wang, X. Le, N.A. Khan, and K. Xie Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis Cancer Res. 60 2000 2579 2583 (Pubitemid 30318227)
34. T. Iwasaki, M. Higashiyama, K. Kuriyama, A. Sasaki, M. Mukai, and K. Shinkai NG-nitro-L-arginine methyl ester inhibits bone metastasis after modified intracardiac injection of human breast cancer cells in a nude mouse model Jpn J. Cancer Res. 88 1997 861 866 (Pubitemid 27475088)
35. A. Siegert, C. Rosenberg, W.D. Schmitt, C. Denkert, and S. Hauptmann Nitric oxide of human colorectal adenocarcinoma cell lines promotes tumour cell invasion Br. J. Cancer. 86 2002 1310 1315
36. V.T. Fabris, C. Lodillinsky, M.B. Pampena, D. Belgorosky, C. Lanari, and A.M. Eijan Cytogenetic characterization of the murine bladder cancer model MB49 and the derived invasive line MB49-I Cancer Genet. 205 2012 168 176
37. S. Babykutty, P. Suboj, P. Srinivas, A.S. Nair, K. Chandramohan, and S. Gopala Insidious role of nitric oxide in migration/invasion of colon cancer cells by upregulating MMP-2/9 via activation of cGMP-PKG-ERK signaling pathways Clin. Exp. Metastasis 29 2012 471 492
38. S. Babaei, K. Teichert-Kuliszewska, J.C. Monge, F. Mohamed, M.P. Bendeck, and D.J. Stewart Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor Circ. Res. 82 1998 1007 1015 (Pubitemid 28225941)
39. L.A. Ridnour, J.S. Isenberg, M.G. Espey, D.D. Thomas, D.D. Roberts, and D.A. Wink Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1 Proc. Natl. Acad. Sci. USA 102 2005 13147 13152 (Pubitemid 41324993)
40. A.M. Eijan, I. Piccardo, M.D. Riveros, E.O. Sandes, H. Porcella, and M.A. Jasnis Nitric oxide in patients with transitional bladder cancer J. Surg. Oncol. 81 2002 203 208 (Pubitemid 35397152)
41. K. Takaoka, S. Hidaka, S. Hashitani, Y. Zushi, M. Yamamura, and E. Segawa Effect of NOS inhibitors and CXCR4 antagonist on tumor growth and metastasis of human adenoid cystic carcinoma xenografted into nude mice Int. J. Oral Maxillofac. Surg. 40 2011
42. F. Okada, H. Tazawa, T. Kobayashi, M. Kobayashi, and M. Hosokawa Involvement of reactive nitrogen oxides for acquisition of metastatic properties of benign tumors in a model of inflammation-based tumor progression Nitric Oxide 14 2006 122 129 (Pubitemid 43165877)
43. F.W. Flitney, R.J. Pritchard, G.D. Kennovin, S.K. Bisland, D.G. Hirst, and S.P. Fricker Antitumor actions of ruthenium(III)-based nitric oxide scavengers and nitric oxide synthase inhibitors Mol. Cancer Ther. 10 2011 1571 1580